Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDHoth Therapeutics Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q2 2026 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q3 2026 | 1 | -$0.15 | -$0.15 | -$0.15 |
| Q4 2026 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q1 2027 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q2 2027 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q3 2027 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q4 2027 | 1 | -$0.19 | -$0.19 | -$0.19 |
| Q1 2028 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q2 2028 | 1 | -$0.29 | -$0.29 | -$0.29 |
| Q3 2028 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q4 2028 | 1 | -$0.32 | -$0.32 | -$0.32 |
Hoth Therapeutics Inc Earnings Date And Information
Hoth Therapeutics Inc last posted its earnings results on Friday, March 27th, 2026. The company reported $-0.16 earnings per share for the quarter, missing analysts' consensus estimates of $-0.1031 by $0.0569. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Hoth Therapeutics Inc has generated $-1 earnings per share over the last year ($-0.9 diluted earnings per share) and currently has a price-to-earnings ratio of -0.82. Hoth Therapeutics Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Hoth Therapeutics Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/27/2026 | Q4 2025 | -$0.10 | -$0.17 | -0.07 | $0 | $0 |
| 11/12/2025 | Q3 2025 | -$0.30 | -$0.30 | 0 | $0 | $0 |
| 08/12/2025 | Q2 2025 | -$0.27 | -$0.17 | 0.1 | N/A | $0 |
| 05/12/2025 | Q1 2025 | -$0.34 | -$0.36 | -0.02 | N/A | $0 |
| 03/28/2025 | Q4 2024 | -$0.39 | -$0.33 | 0.06 | N/A | $0 |
| 11/12/2024 | Q3 2024 | -$0.30 | -$0.31 | -0.01 | N/A | $0 |
| 08/09/2024 | Q2 2024 | -$0.39 | -$0.24 | 0.15 | N/A | $0 |
| 05/14/2024 | Q1 2024 | -$0.43 | -$0.46 | -0.03 | N/A | $0 |
| 03/28/2024 | Q4 2023 | -$0.51 | -$0.39 | 0.12 | N/A | $0 |
| 11/13/2023 | Q3 2023 | -$0.72 | -$0.60 | 0.12 | N/A | $0 |
| 08/11/2023 | Q2 2023 | -$1.16 | -$0.57 | 0.59 | N/A | $0 |
| 05/15/2023 | Q1 2023 | -$0.86 | -$0.88 | -0.02 | N/A | $0 |
| 03/31/2023 | Q4 2022 | -$2.29 | -$3.19 | -0.9 | N/A | $0 |
| 11/10/2022 | Q3 2022 | -$2.39 | -$2.02 | 0.37 | N/A | $0 |
| 08/12/2022 | Q2 2022 | -$2.25 | -$2.16 | 0.09 | N/A | $0 |
| 05/12/2022 | Q1 2022 | -$2.75 | -$2.59 | 0.16 | N/A | $0 |
| 03/29/2022 | Q4 2021 | -$3.00 | -$3.90 | -0.9 | N/A | $0 |
| 11/10/2021 | Q3 2021 | -$3.75 | -$3.45 | 0.3 | N/A | $0 |
| 08/11/2021 | Q2 2021 | -$4.50 | -$3.46 | 1.04 | N/A | $0 |
| 05/13/2021 | Q1 2021 | -$2.50 | -$6.03 | -3.53 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Hoth Therapeutics Inc Earnings: FAQ's
The conference call for Hoth Therapeutics Inc's latest earnings report can be listened to online.
The conference call transcript for Hoth Therapeutics Inc's latest earnings report can be read online.
Hoth Therapeutics Inc (:HOTH) has a recorded net income of $-12,469,302.Hoth Therapeutics Inc has generated $-0.9 earnings per share over the last four quarters.
Hoth Therapeutics Inc (:HOTH) has a price-to-earnings ratio of -0.82 and price/earnings-to-growth ratio is -0.03.